D Factory | China D Manufacturers, Suppliers

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Dabrafenib (CAS: 1195765-45-7)

API’s Name Indication Innovator Patent Expiry Date(The U.S)

Dabrafenib Melanoma Novartis

（GSK R&D）
Jul.20, 2030

inquiry detail
Darolutamide (CAS: 1297538-32-9)

API’s Name Indication Innovator Patent Expiry Date(The U.S)

Darolutamide prostatic cancer treatment Bayer Mar. 25,2033

inquiry detail
Deucracitinib

API’s Name Indication Innovator Patent Expiry Date(The U.S)

Deucracitinib Anti plaque psoriasis Bristol-Myers Squibb Company Nov.07,2033

inquiry detail
Dabigatran Etexilate Mesylate

API’s Name Indication Specification US DMF EU DMF CEP

Dabigatran Etexilate Mesylate Anticoagulant In-House

inquiry detail
Daclatasvir Dihydrochloride

API’s Name Indication Specification US DMF EU DMF CEP

Daclatasvir Dihydrochloride HCV In-House √

inquiry detail
Doxycycline Monohydrate

API’s Name Indication Specification US DMF EU DMF CEP

Doxycycline Mono Antibiotics USP/EP 18959 √

inquiry detail
Doxycycline Hyclate

API’s Name Indication Specification US DMF EU DMF CEP

Doxycycline Hyclate Antibiotics USP/EP 13771 √

inquiry detail